Max Healthcare Institute share price
Max Healthcare Institute Ltd. · NSE: MAXHEALTH · Healthcare
Price, one year
Price range
- Open
- ₹810.50
- High
- ₹819.40
- Low
- ₹803.00
- Previous close
- ₹817.00
- Volume
- 16.6 L
- Market cap
- ₹79,412 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 54.5
- Price to book
- 7.4
- Return on equity
- 13.6%
- EPS (TTM)
- ₹14.99
- Book value / share
- ₹110.41
- Debt to equity
- 0.32
- Revenue (TTM)
- ₹8,712 Cr
- Net profit (TTM)
- ₹1,457 Cr
- Sales growth, YoY
- +16.7%
- Profit growth, YoY
- +4.9%
- Operating margin
- 26.6%
- Net margin
- 16.7%
- Sales CAGR, 3 years
- +22.4%
- Profit CAGR, 3 years
- +9.3%
- Promoter holding
- 23.71%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 23.71 | 23.71 | 23.71 |
| Foreign institutions | 45.39 | 41.78 | 40.52 |
| Domestic institutions | 26.32 | 29.96 | 31.00 |
| Mutual funds | 16.30 | 18.68 | 19.25 |
| Retail and others | 3.27 | 3.22 | 3.28 |
Futures and options
22 Oct 2026- Lot size
- 525
- Put-call ratio (OI)
- 0.63
- Max pain
- ₹890.00
- Highest call OI strike
- 1,000.00
- Highest put OI strike
- 900.00
- ATM implied volatility
- 33.4% IV rank 86
- Futures basis
- −0.02%
- Rollover
- 29.4%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 22 Oct | Short buildup | −0.06% | +2.13% |
| 21 Oct | Short buildup | −1.92% | +7.50% |
| 19 Oct | Long unwinding | −1.93% | −1.83% |
| 16 Oct | Short buildup | −1.33% | +4.52% |
| 15 Oct | Long buildup | +0.56% | +0.10% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 13 Aug 2026.
- 19 Oct 2026 · OtherGeneral UpdatesMax Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- 16 Oct 2026 · OtherGeneral UpdatesMax Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,740.10 | −1.02% |
| Divi's LaboratoriesDIVISLAB | ₹8,884.00 | −3.03% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,486.60 | −2.79% |
| Zydus LifesciencesZYDUSLIFE | ₹1,124.60 | −0.92% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,579.00 | −0.34% |
| CiplaCIPLA | ₹1,319.00 | −0.89% |
| Laurus LabsLAURUSLABS | ₹1,943.10 | −2.97% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,226.70 | −0.99% |
| Mankind PharmaMANKIND | ₹2,228.10 | −2.09% |
| Aurobindo PharmaAUROPHARMA | ₹1,557.20 | −3.33% |
Frequently asked questions
What is the share price of Max Healthcare Institute today?
Max Healthcare Institute (NSE: MAXHEALTH) was at ₹815.90 on 23 Oct 2026, a change of −0.13% from the previous close.
What are the 52-week high and low of Max Healthcare Institute?
Over the last 52 weeks Max Healthcare Institute traded between ₹797.00 and ₹1,221.90 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Max Healthcare Institute?
About ₹79,412 Cr at the latest price, with a P/E of 54.5, a price-to-book of 7.4, a return on equity of 13.6%. Ratios use the company's latest reported results.
Who owns Max Healthcare Institute shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 23.71%, foreign institutions 40.52%, domestic institutions 31.00%.
Is Max Healthcare Institute traded in futures and options?
Yes, MAXHEALTH is in NSE's futures and options segment. The lot size is 525 shares.
Which sector and indices does Max Healthcare Institute belong to?
NSE classifies Max Healthcare Institute under Healthcare; it is a member of Nifty 50, Nifty 100, Nifty 500.
Follow Max Healthcare Institute with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Get started free